ACTIVATION OF ONCOGENES IN HUMAN ORAL-CANCER CELLS - A NOVEL CODON-13 MUTATION OF C-H-RAS-1 AND CONCURRENT AMPLIFICATIONS OF C-ERBB-1 AND C-MYC

被引：1
|
作者：
TADOKORO, K
UEDA, M
OHSHIMA, T
FUJITA, K
RIKIMARU, K
TAKAHASHI, N
ENOMOTO, S
TSUCHIDA, N
机构：
[1] TOKYO MED & DENT UNIV,FAC DENT,DEPT ORAL MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN
[2] TOKYO MED & DENT UNIV,FAC DENT,DEPT ORAL & MAXILLOFACIAL SURG 2,BUNKYO KU,TOKYO 113,JAPAN
来源：
ONCOGENE | 1989年 / 4卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：499 / 505
页数：7
相关论文
共 50 条
  • [21] The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes
    Barr, LF
    Campbell, SE
    Tamez, P
    Casero, RA
    CLINICAL CANCER RESEARCH, 1998, 4 (06) : 1557 - 1561
  • [22] Modes of Action of a Novel c-MYC Inhibiting 1,2,4-Oxadiazole Derivative in Leukemia and Breast Cancer Cells
    Zhou, Min
    Boulos, Joelle C.
    Omer, Ejlal A.
    Klauck, Sabine M.
    Efferth, Thomas
    MOLECULES, 2023, 28 (15):
  • [23] Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells
    Zhao, Hong-Ye
    Ooyama, Akio
    Yamamoto, Masatatsu
    Ikeda, Ryuji
    Haraguchi, Misako
    Tabata, Sho
    Furukawa, Tatsuhiko
    Che, Xiao-Fang
    Iwashita, Ken-ichi
    Oka, Toshinori
    Fukushima, Masakazu
    Nakagawa, Masayuki
    Ono, Mayumi
    Kuwano, Michihiko
    Akiyama, Shin-ichi
    CANCER LETTERS, 2008, 270 (01) : 156 - 163
  • [24] Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells
    Yang, J
    Deng, X
    Deng, L
    Gu, H
    Fan, W
    Cao, Y
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2004, 23 (03): : 495 - 506
  • [25] MODULATION OF LFA-1 SURFACE-ANTIGEN EXPRESSION BY ACTIVATED H-RAS BUT NOT C-MYC ONCOGENE IN EBV-INFECTED HUMAN B-LYMPHOBLAST CELLS
    ENDO, K
    BORER, CH
    TSUJIMOTO, Y
    ONCOGENE, 1991, 6 (08) : 1391 - 1396
  • [26] ACTIVATION OF K-RAS BY CODON 13 MUTATIONS IN C57BL/6 X C3H F1 MOUSE-TUMORS INDUCED BY EXPOSURE TO 1,3-BUTADIENE
    GOODROW, T
    REYNOLDS, S
    MARONPOT, R
    ANDERSON, M
    CANCER RESEARCH, 1990, 50 (15) : 4818 - 4823
  • [27] Cdx1 expression inhibits cyclin D1 and c-Myc expression and β-catenin/TCF transcriptional activity in human colon cancer cells
    Guo, RJ
    Patel, N
    Lynch, JP
    GASTROENTEROLOGY, 2003, 124 (04) : A110 - A110
  • [28] c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells
    Mukherjee, S
    Conrad, SE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (18) : 17617 - 17625
  • [29] ALTERATIONS OF ERBB-1 (HER-1), ERBB-2 (HER-2/NEU), C-MYC AND HRAS-1 ONCOGENES, P53 AND RB-1 SUPPRESSOR GENES, AND LOSSES OF GENETIC MATERIAL AT THE CHROMOSOME-17 IN HUMAN OVARIAN CARCINOMAS
    IMYANITOV, EN
    CHERNITSA, OI
    NIKIFOROVA, IF
    SEROVA, OM
    SOKOLOV, SI
    YURKOVA, LE
    VINOKUROV, VL
    TOGO, AV
    KNYAZEV, PG
    EKSPERIMENTALNAYA ONKOLOGIYA, 1993, 15 (06): : 41 - 43
  • [30] Chronic iron exposure and c-Myc/H-ras-mediated transformation in fallopian tube cells alter the expression of EVI1, amplified at 3q26.2 in ovarian cancer
    Stephanie Rockfield
    Younghoon Kee
    Meera Nanjundan
    Oncogenesis, 8
12345